Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 51, 2022 - Issue 5
87
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Influence of HLA Class II Alleles and DRB1-DQB1 Haplotypes on Rheumatoid Arthritis Susceptibility and Autoantibody Status in the Chinese Han Population

ORCID Icon, , , , , & show all

References

  • Achour Y, Ben Hamad M, Chaabane S, Rebai A, Marzouk S, Mahfoudh N, Bahloul Z, Keskes L, Maalej A. 2017. Analysis of two susceptibility SNPs in HLA region and evidence of interaction between rs6457617 in HLA-DQB1 and HLA-DRB1*04 locus on Tunisian rheumatoid arthritis. J Genet. 96:911–18.
  • Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 69:1580–88.
  • Asquith M, Sternes PR, Costello ME, Karstens L, Diamond S, Martin TM, Li Z, Marshall MS, Spector TD, Le Cao KA, et al. 2019. HLA alleles associated with risk of ankylosing spondylitis and rheumatoid arthritis influence the gut microbiome. Arthritis Rheumatol. 71:1642–50.
  • Balandraud N, Picard C, Reviron D, Landais C, Toussirot E, Lambert N, Telle E, Charpin C, Wendling D, Pardoux E, et al. 2013. HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritis. PLoS One. 8:64108.
  • Boissier MC, Biton J, Semerano L, Decker P, Bessis N. 2020. Origins of rheumatoid arthritis. Joint Bone Spine. 87:301–06.
  • Burmester GR, Pope JE. 2017. Novel treatment strategies in rheumatoid arthritis. Lancet. 389:2338–48.
  • Cappelli LC, Dorak MT, Bettinotti MP, Bingham CO, Shah AA. 2019. Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis. Rheumatology (Oxford). 58:476–80.
  • Chinniah R, Rajendran MS, Sivanadham R, Adaikalam ML, Ravi PM, Vijayan M, Boopathy S, Pandi S, Sevak V, Karuppiah B. 2019. Association of HLA class II alleles/haplotypes and amino acid variations in the peptide binding pockets with rheumatoid arthritis. Int J Rheum Dis. 22:1553–62.
  • Chun-Lai T, Padyukov L, Dhaliwal JS, Lundström E, Yahya A, Muhamad NA, Klareskog L, Alfredsson L, Larsson PT, Murad S; Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA) Study Group. 2011. Shared epitope alleles remain a risk factor for anti-citrullinated proteins antibody (ACPA)–positive rheumatoid arthritis in three Asian ethnic groups. PLoS One. 6:21069.
  • Conigliaro P, Triggianese P, De Martino E, Fonti GL, Chimenti MS, Sunzini F, Viola A, Canofari C, Perricone R. 2019. Challenges in the treatment of Rheumatoid arthritis. Autoimmun Rev. 18:706–13.
  • Croia C, Bursi R, Sutera D, Petrelli F, Alunno A, Puxeddu I. 2019. One year in review 2019: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 37:347–57.
  • Derksen VFAM, Huizinga TWJ, van der Woude D. 2017. The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol. 39:437–46.
  • Furukawa H, Oka S, Shimada K, Hashimoto A, Komiya A, Tsunoda S, Suda A, Ito S, Saisho K, Katayama M, et al. 2018. Independent association of HLA-DPB1*02:01 with rheumatoid arthritis in Japanese populations. PLoS One. 13:0204459.
  • Gautam S, Kumar U, Kumar M, Kanga U, Dada R. 2020. Association of HLA-G 3ʹUTR polymorphisms with soluble HLA-G levels and disease activity in patients with Rheumatoid arthritis: a case-control study. Immunol Invest. 49:88–105.
  • Gerstner C, Turcinov S, Hensvold AH, Chemin K, Uchtenhagen H, Ramwadhdoebe TH, Dubnovitsky A, Kozhukh G, Rönnblom L, Kwok WW, et al. 2020. Multi-HLA class II tetramer analyses of citrulline-reactive T cells and early treatment response in rheumatoid arthritis. BMC Immunol. 21:27.
  • Gunasekera WM, Kirwan JR. 2016. Rheumatoid arthritis: previously untreated early disease. BMJ Clin Evid. 2016:1124.
  • Huang Z, Niu Q, Yang B, Zhang J, Yang M, Xu H, Cai B, Hu J, Wu Y, Wang L. 2018. Genetic polymorphism of rs9277535 in HLA-DP associated with rheumatoid arthritis and anti-CCP production in a Chinese population. Clin Rheumatol. 37:1799–805.
  • Iranshahi N, Assar S, Amiri SM, Zafari P, Fekri A, Taghadosi M. 2019. Decreased gene expression of epstein-barr virus-induced gene 3 (EBI-3) may contribute to the pathogenesis of Rheumatoid arthritis. Immunol Invest. 48:367–77.
  • Jia Y, Su T, Gu Y, Li C, Zhou X, Su J, Sun P, Tang J, Yang L, Liu G, et al. 2018. HLA-DQA1, -DQB1, and -DRB1 alleles associated with acute tubulointerstitial nephritis in a Chinese population: a single-center cohort study. J Immunol. 201:423–31.
  • Jiang L, Jiang D, Han Y, Shi X, Ren C. 2018. Association of HLA-DPB1 polymorphisms with rheumatoid arthritis: a systemic review and meta-analysis. Int J Surg. 52:98–104.
  • Kanaan SB, Sensoy O, Yan Z, Gadi VK, Richardson ML, Nelson JL. 2019. Immunogenicity of a rheumatoid arthritis protective sequence when acquired through microchimerism. Proc Natl Acad Sci USA. 116:19600–08.
  • Kissel T, Van Schie KA, Hafkenscheid L, Lundquist A, Kokkonen H, Wuhrer M, Huizinga TW, Scherer HU, Toes R, Rantapää-Dahlqvist S. 2019. On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritis. Ann Rheum Dis. 78:1616–20.
  • Klimenta B, Nefic H, Prodanovic N, Jadric R, Hukic F. 2019. Association of biomarkers of inflammation and HLA-DRB1 gene locus with risk of developing rheumatoid arthritis in females. Rheumatol Int. 39:2147–57.
  • Köhler BM, Günther J, Kaudewitz D, Lorenz HM. 2019. Current therapeutic options in the treatment of Rheumatoid arthritis. J Clin Med. 8:938.
  • Lagha A, Messadi A, Boussaidi S, Kochbati S, Tazeghdenti A, Ghazouani E, Almawi WY, Yacoubi-Loueslati B. 2016. HLA DRB1/DQB1 alleles and DRB1-DQB1 haplotypes and the risk of rheumatoid arthritis in Tunisians: a population-based case-control study. HLA. 88:100–09.
  • Liu WX, Jiang Y, Hu QX, You XB. 2016. HLA-DRB1 shared epitope allele polymorphisms and rheumatoid arthritis: a systemic review and meta-analysis. Clin Invest Med. 39:182–203.
  • Macfarlane FR, Chaplain MAJ, Eftimie R. 2019. Quantitative predictive modelling approaches to understanding rheumatoid Arthritis: a brief review. Cells. 9:74.
  • Mariaselvam CM, Fortier C, Charron D, Krishnamoorthy R, Tamouza R, Negi VS. 2016. HLA class II alleles influence rheumatoid arthritis susceptibility and autoantibody status in South Indian Tamil population. HLA. 88:253–58.
  • Oka S, Furukawa H, Kawasaki A, Shimada K, Sugii S, Hashimoto A, Komiya A, Fukui N, Ito S, Nakamura T, et al. 2014. Protective effect of the HLA-DRB1*13:02 allele in Japanese rheumatoid arthritis patients. PLoS One. 9:99453.
  • Oka S, Furukawa H, Shimada K, Hashimoto A, Komiya A, Tsunoda S, Saisho K, Tsuchiya N, Katayama M, Shinohara S, et al. 2019. Association of HLA-DRB1 genotype with younger age onset and elder age onset rheumatoid arthritis in Japanese populations. Medicine (Baltimore). 98:18218.
  • Okada Y, Eyre S, Suzuki A, Kochi Y, Yamamoto K. 2019. Genetics of rheumatoid arthritis: 2018 status. Ann Rheum Dis. Apr;78:446–53.
  • Raslan HM, Attia HR, Salama I, Ibrahim MH, Hassan EM, El Hussieny MS, El Menyawi MM, Amr KS. 2016. Association of PTPN22 1858C→T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis. Rheumatol Int. 36:1167–75.
  • Sakr BR, Elfishawi MM, ElArousy MH, Hatw AK, AbdulKarim AN, Tammam AB, Kotp AN, Hamed ME, Genedy IE, Desouky EDE, et al. 2018. Rheumatoid arthritis: a single-center Egyptian experience. Immunol Invest. 47:293–302.
  • Smolen JS, Aletaha D, McInnes IB. 2016. Rheumatoid arthritis. Lancet. 388:2023–38.
  • Terao C, Raychaudhuri S, Gregersen PK. 2016. Recent advances in defining the genetic basis of Rheumatoid arthritis. Annu Rev Genomics Hum Genet. 17:273–301.
  • Trier NH, Houen G. 2017. Epitope specificity of anti-citrullinated protein antibodies. Antibodies (Basel). 6:5.
  • Wang J, Zhang H, Wang GQ, Quan Y. 2016. HLA-DRB1 gene polymorphisms and its associations with rheumatoid arthritis in Chinese Han women of Shaanxi province, northwest of China. Int J Immunogenet. 43:25–31.
  • Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, Aletaha D, Van Riel PL. 2009. Validation of the 28-joint disease activity score (DAS28) and European league against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 68:954–60.
  • Wu J, Li J, Li S, Zhang TP, Li LJ, Lv TT, Pan HF, Ye DQ. 2017. Association of HLA-DQB1 polymorphisms with rheumatoid arthritis: a meta-analysis. Postgrad Med J. 93:618–25.
  • Wysocki T, Olesińska M, Paradowska-Gorycka A. 2020. Current understanding of an emerging role of HLA-DRB1 gene in rheumatoid arthritis-from research to clinical practice. Cells. 9:1127.
  • Yin J, He D, Jiang L, Cheng F, Guo Q, Huang S, Zeng X, Liu Y, Brown MA, Xu H. 2017. Influence of cigarette smoking on rheumatoid arthritis risk in the Han Chinese population. Front Med (Lausanne). 4:76.
  • Zhao M, Mauer L, Sayles H, Cannon GW, Reimold A, Kerr GS, Baker JF, Thiele GM, England BR, Mikuls TR. 2019. HLA-DRB1 haplotypes, shared epitope, and disease outcomes in US veterans with Rheumatoid arthritis. J Rheumatol. 46:685–93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.